Literature DB >> 28706868

Tricuspid valve endocarditis.

Syed T Hussain1, James Witten2, Nabin K Shrestha3, Eugene H Blackstone1,4, Gösta B Pettersson1.   

Abstract

Right-sided infective endocarditis (RSIE) is less common than left-sided infective endocarditis (IE), encompassing only 5-10% of cases of IE. Ninety percent of RSIE involves the tricuspid valve (TV). Given the relatively small numbers of TVIE cases operated on at most institutions, the purpose of this review is to highlight and discuss the current understanding of IE involving the TV. RSIE and TVIE are strongly associated with intravenous drug use (IVDU), although pacemaker leads, defibrillator leads and vascular access for dialysis are also major risk factors. Staphylococcus aureus is the predominant causative organism in TVIE. Most patients with TVIE are successfully treated with antibiotics, however, 5-16% of RSIE cases eventually require surgical intervention. Indications and timing for surgery are less clear than for left-sided IE; surgery is primarily considered for failed medical therapy, large vegetations and septic pulmonary embolism, and less often for TV regurgitation and heart failure. Most patients with an infected prosthetic TV will require surgery. Concomitant left-sided IE has its own surgical indications. Earlier surgical intervention may potentially prevent further destruction of leaflet tissue and increase the likelihood of TV repair. Fortunately, TV debridement and repair can be accomplished in most cases, even those with extensive valve destruction, using a variety of techniques. Valve repair is advocated over replacement, particularly in IVDUs patients who are young, non-compliant and have a higher risk of recurrent infection and reoperation with valve replacement. Excising the valve without replacing, it is not advocated; it has been reported previously, but these patients are likely to be symptomatic, particularly in cases with septic pulmonary embolism and increased pulmonary vascular resistance. Patients with concomitant left-sided involvement have worse prognosis than those with RSIE alone, due predominantly to greater likelihood of invasion and abscess formation in left-sided IE. Patients with isolated TVIE have an operative mortality between 0-15% and excellent survival.

Entities:  

Keywords:  Tricuspid valve (TV); infective endocarditis (IE); right-sided endocarditis

Year:  2017        PMID: 28706868      PMCID: PMC5494428          DOI: 10.21037/acs.2017.03.09

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN: 2225-319X


  26 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

Review 2.  Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis.

Authors:  J A Frontera; J D Gradon
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

3.  Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database.

Authors:  Christopher H Cabell; Elias Abrutyn; Vance G Fowler; Bruno Hoen; Jose M Miro; G Ralph Corey; Lars Olaison; Paul Pappas; Kevin J Anstrom; Judith A Stafford; Susannah Eykyn; Gilbert Habib; Carlos A Mestres; Andrew Wang
Journal:  Am Heart J       Date:  2005-11       Impact factor: 4.749

4.  Long-term clinical results of tricuspid valve replacement.

Authors:  Byung-Chul Chang; Sang-Hyun Lim; Gijong Yi; You Sun Hong; Sak Lee; Kyung-Jong Yoo; Meyun Shick Kang; Bum Koo Cho
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

5.  Long-term outcomes of tricuspid valve replacement in the current era.

Authors:  Farzan Filsoufi; Ani C Anyanwu; Sacha P Salzberg; Tim Frankel; Lawrence H Cohn; David H Adams
Journal:  Ann Thorac Surg       Date:  2005-09       Impact factor: 4.330

6.  Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment.

Authors:  Antonio Carozza; Luca Salvatore De Santo; Gianpaolo Romano; Alessandro Della Corte; Fabio Ursomando; Michelangelo Scardone; Giuseppe Caianiello; Maurizio Cotrufo
Journal:  J Heart Valve Dis       Date:  2006-01

Review 7.  Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients.

Authors:  José M Miró; Ana del Río; Carlos A Mestres
Journal:  Cardiol Clin       Date:  2003-05       Impact factor: 2.213

8.  Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis.

Authors:  Roman Gottardi; Jan Bialy; Elena Devyatko; Heinz Tschernich; Martin Czerny; Ernst Wolner; Rainald Seitelberger
Journal:  Ann Thorac Surg       Date:  2007-12       Impact factor: 4.330

9.  In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes.

Authors:  Anders Thalme; Katarina Westling; Inger Julander
Journal:  Scand J Infect Dis       Date:  2007

10.  Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience.

Authors:  Michele Musci; Henryk Siniawski; Miralem Pasic; Onnen Grauhan; Yuguo Weng; Rudolf Meyer; Charles A Yankah; Roland Hetzer
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-06       Impact factor: 4.191

View more
  23 in total

1.  Tricuspid Valve Leaflet Repair and Augmentation for Infective Endocarditis.

Authors:  Alexander A Brescia; Tessa M F Watt; Aaron M Williams; Matthew A Romano; Steven F Bolling
Journal:  Oper Tech Thorac Cardiovasc Surg       Date:  2019-10-25

2.  Tricuspid Valve Infective Endocarditis Due to Klebsiella pneumoniae in Intravenous Drug User.

Authors:  Tanawan Riangwiwat; Jonathan Dworkin
Journal:  Hawaii J Med Public Health       Date:  2019-03

3.  Tricuspid Valve Endocarditis in Four Patients with Unrepaired Restrictive Perimembranous Ventricular Septal Defects.

Authors:  Adam M Butensky; Alexandra Channing; Andrew S Handel; David Kalfa; Stuart Holzer
Journal:  Pediatr Cardiol       Date:  2022-06-03       Impact factor: 1.838

Review 4.  Current surgical strategies and techniques of aortic valve diseases in children.

Authors:  Kun Wang; Huifeng Zhang; Bing Jia
Journal:  Transl Pediatr       Date:  2018-04

5.  Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission.

Authors:  Hugues Georges; Olivier Leroy; Norair Airapetian; Nicolas Lamblin; Elie Zogheib; Patrick Devos; Sebastien Preau
Journal:  BMC Infect Dis       Date:  2018-02-21       Impact factor: 3.090

6.  Anterior leaflet repair in tricuspid valve infective endocarditis.

Authors:  Laszlo Göbölös; Maurice Hogan; Tareq Aleinati; Rakesh Suri
Journal:  Eur Heart J Case Rep       Date:  2020-03-17

7.  Pulmonary artery intravascular abscess: A rare complication of incomplete infective endocarditis treatment in the setting of injection drug use.

Authors:  Simran Gupta; David B Banach; Lisa M Chirch
Journal:  IDCases       Date:  2018-03-30

8.  Valvectomy versus replacement for the surgical treatment of infective tricuspid valve endocarditis: a systematic review and meta-analysis.

Authors:  Jessica G Y Luc; Jae-Hwan Choi; Karishma Kodia; Matthew P Weber; Dylan P Horan; Elizabeth J Maynes; Laura A Carlson; H Todd Massey; John W Entwistle; Rohinton J Morris; Vakhtang Tchantchaleishvili
Journal:  Ann Cardiothorac Surg       Date:  2019-11

9.  Characteristics and outcomes of patients with right-sided endocarditis undergoing cardiac surgery.

Authors:  Carolyn Weber; Asmae Gassa; Kaveh Eghbalzadeh; Julia Merkle; Ilija Djordjevic; Johanna Maier; Anton Sabashnikov; Antje-Christin Deppe; Elmar W Kuhn; Parwis B Rahmanian; Oliver J Liakopoulos; Thorsten Wahlers
Journal:  Ann Cardiothorac Surg       Date:  2019-11

10.  Systemic septic emboli in tricuspid endocarditis due to an atrial communication with a right-to-left shunt.

Authors:  Olivia Farrant; Gabriella Scozzi; Rebecca Hughes
Journal:  BMJ Case Rep       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.